Cargando…
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
BACKGROUND: Prospective data on maintenance therapy with bevacizumab for persons with NF2-related schwannomatosis (NF2-SWN) is lacking. In this prospective multicenter phase II study, we evaluated the efficacy, safety, and tolerability of bevacizumab for maintenance therapy in children and adults wi...
Autores principales: | Plotkin, Scott R, Allen, Jeffrey, Dhall, Girish, Campian, Jian L, Clapp, D Wade, Fisher, Michael J, Jain, Rakesh K, Tonsgard, James, Ullrich, Nicole J, Thomas, Coretta, Edwards, Lloyd J, Korf, Bruce, Packer, Roger, Karajannis, Matthias A, Blakeley, Jaishri O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398799/ https://www.ncbi.nlm.nih.gov/pubmed/37010875 http://dx.doi.org/10.1093/neuonc/noad066 |
Ejemplares similares
-
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
por: Webb, M J, et al.
Publicado: (2023) -
NFB-17. MEK INHIBITOR BINIMETINIB SHOWS CLINICAL ACTIVITY IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1- ASSOCIATED PLEXIFORM NEUROFIBROMAS: A REPORT FROM PNOC AND THE NF CLINICAL TRIALS CONSORTIUM
por: Mueller, Sabine, et al.
Publicado: (2020) -
Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series
por: Douwes, Jules P. J., et al.
Publicado: (2023) -
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023) -
The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma
por: Gregory, Grace E, et al.
Publicado: (2023)